[{"AccountsPayableCurrent_0_Q1_USD":1694000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":213000.0,"AssetsFairValueDisclosure_0_Q1_USD":336529000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":1912000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5152000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-12000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":104700000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5152000.0,"PaymentsForRoyalties_1_Q1_USD":1240000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1224000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-69000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1054000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":203948000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":31373000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":181579000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-314000.0,"OperatingCostsAndExpenses_1_Q1_USD":819000.0,"InvestmentIncomeInterest_1_Q1_USD":975000.0,"DeferredRevenueCurrent_0_Q1_USD":1287000.0,"DeferredRevenue_0_Q1_USD":3479000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-53314000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1092829000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":535000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":181257000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":149884000.0,"AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear_0_Q1_Securities":41.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":987000.0,"ReceivablesNetCurrent_0_Q1_USD":9281000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":47413000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":2733000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":93882000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":10320000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":12746000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1711000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q1_USD":817000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":3350000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":161802000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q1_USD":2300000.0,"DeferredRevenueNoncurrent_0_Q1_USD":2192000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":535000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":94804000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":535000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":94804000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":294000.0,"DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_0_Q1_USD":67900000.0,"DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_1_Q1_USD":0.0,"DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_1_Q1_D":5.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":73259000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-80000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":714000.0,"NonoperatingIncomeExpense_1_Q1_USD":-5509000.0,"InventoryFinishedGoods_0_Q1_USD":153000.0,"NetIncomeLoss_1_Q1_USD":-52931000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-45011000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-46479000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":164829000.0,"LiabilitiesCurrent_0_Q1_USD":49699000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":416141000.0,"Liabilities_0_Q1_USD":249994000.0,"InventoryNet_0_Q1_USD":970000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":268000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1419000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":711000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":66000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-52865000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.78,"CommonStockValue_0_Q1_USD":7000.0,"CommonStockSharesOutstanding_0_Q1_shares":73095000.0,"CommonStockSharesIssued_0_Q1_shares":73095000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":202247000.0,"AssetsCurrent_0_Q1_USD":370920000.0,"Assets_0_Q1_USD":416141000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-420000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":10000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7551000.0,"ProfitLoss_1_Q1_USD":-52931000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2814000.0,"IncreaseDecreaseInInventories_1_Q1_USD":624000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2733000.0,"ShareBasedCompensation_1_Q1_USD":5152000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":30678000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":33997000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":172500000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":25000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingExpenses_1_Q1_USD":65494000.0,"InterestExpense_1_Q1_USD":6509000.0,"DepreciationAndAmortization_1_Q1_USD":242000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":111769000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q1_USD":43783000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":67627.0,"StockholdersEquity_0_Q1_USD":166147000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-926269000.0,"OperatingIncomeLoss_1_Q1_USD":-47356000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":18138000.0,"Ticker":"KPTI","CIK":"1503802","name":"KARYOPHARM THERAPEUTICS INC.","OfficialName":"Karyopharm Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"566245834.0","Country":"United States","Sector":"Miscellaneous","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]